Sungwon was Executive Director at MAPS Capital, and Director at Mirae Asset Global Investments. Sungwon Song joined EpimAb Biotherapeutics in 2023.
Sungwon Song is currently
Create your alert
to follow the career of Sungwon Song.
Sungwon Song has a Master in Biotechnology from Columbia University and a PhD from Ohio State University.
They have also studied at Columbia University :
Find more alumni from Columbia University
They have also studied at Ohio State University :
Find more alumni from Ohio State University
Do you need to know more about Sungwon Song? More results.
Report an error
Update the org chart details of Sungwon Song.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.